טוען...

Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.

The objective of this study was to estimate the net cost of arsenic trioxide (ATO) added to all-trans retinoic acid (ATRA) compared to ATRA plus chemotherapy when used in first-line acute promyelocytic leukemia (APL) treatment for low to intermediate risk patients from the perspective of the overall...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Morgan Kruse, Rebecca Wildner, Gisoo Barnes, Monique Martin, Udo Mueller, Francesco Lo-Coco, Ashutosh Pathak
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science (PLoS) 2015-01-01
סדרה:PLoS ONE
גישה מקוונת:http://europepmc.org/articles/PMC4534409?pdf=render
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!